96 related articles for article (PubMed ID: 8585950)
21. Insertional activation of myb by F-MuLV in SCID mice induces myeloid leukemia.
Haeri M; Li Y; Li Y; Li Q; Spaner DE; Ben-David Y
Int J Oncol; 2013 Jul; 43(1):169-76. PubMed ID: 23677281
[TBL] [Abstract][Full Text] [Related]
22. c-Myc is essential but not sufficient for c-Myb-mediated block of granulocytic differentiation.
Kumar A; Lee CM; Reddy EP
J Biol Chem; 2003 Mar; 278(13):11480-8. PubMed ID: 12525485
[TBL] [Abstract][Full Text] [Related]
23. Long-range effects of retroviral insertion on c-myb: overexpression may be obscured by silencing during tumor growth in vitro.
Hanlon L; Barr NI; Blyth K; Stewart M; Haviernik P; Wolff L; Weston K; Cameron ER; Neil JC
J Virol; 2003 Jan; 77(2):1059-68. PubMed ID: 12502821
[TBL] [Abstract][Full Text] [Related]
24. Mutations in multiple domains of c-Myb disrupt interaction with CBP/p300 and abrogate myeloid transforming ability.
Pattabiraman DR; Sun J; Dowhan DH; Ishii S; Gonda TJ
Mol Cancer Res; 2009 Sep; 7(9):1477-86. PubMed ID: 19737967
[TBL] [Abstract][Full Text] [Related]
25. c-myc and c-myb oncoproteins during induced maturation of myeloid and erythroid human leukemic cell lines.
Pedrazzoli P; Bains MA; Watson R; Fisher J; Hoy TG; Jacobs A
Cancer Res; 1989 Dec; 49(24 Pt 1):6911-6. PubMed ID: 2684403
[TBL] [Abstract][Full Text] [Related]
26. Oncogenic activation of c-Myb by carboxyl-terminal truncation leads to decreased proteolysis by the ubiquitin-26S proteasome pathway.
Bies J; Wolff L
Oncogene; 1997 Jan; 14(2):203-12. PubMed ID: 9010222
[TBL] [Abstract][Full Text] [Related]
27. F-MuLV acceleration of myelomonocytic tumorigenesis in SV40 large T antigen transgenic mice is accompanied by retroviral insertion at Fli1 and a novel locus, Fim4.
Kone J; Arroyo J; Savinelli T; Lin S; Boyd K; Wu Y; Nimmakayalu M; Copeland NG; Jenkins NA; Qumsiyeh M; Hu P; Prescott A; Wu H; Yang L; Roe B; Perkins AS
Leukemia; 2002 Sep; 16(9):1827-34. PubMed ID: 12200699
[TBL] [Abstract][Full Text] [Related]
28. Large-scale molecular mapping of human c-myb locus: c-myb proto-oncogene is not involved in 6q- abnormalities of lymphoid tumors.
Park JG; Reddy EP
Oncogene; 1992 Aug; 7(8):1603-9. PubMed ID: 1630821
[TBL] [Abstract][Full Text] [Related]
29. Regulation of cell proliferation: late down-regulation of c-myb preceding myelo-monocytic cell differentiation.
Yen A; Samuel V; Forbes M
J Cell Physiol; 1992 Oct; 153(1):147-56. PubMed ID: 1522128
[TBL] [Abstract][Full Text] [Related]
30. Insertion and truncation of c-myb by murine leukemia virus in a myeloid cell line derived from cultures of normal hematopoietic cells.
Weinstein Y; Cleveland JL; Askew DS; Rapp UR; Ihle JN
J Virol; 1987 Jul; 61(7):2339-43. PubMed ID: 2884332
[TBL] [Abstract][Full Text] [Related]
31. Effects of dexamethasone on induction of monocytic differentiation in human U-937 cells by dimethylsulfoxide.
Nakamura T; Kharbanda S; Spriggs D; Kufe D
J Cell Physiol; 1990 Feb; 142(2):261-7. PubMed ID: 2406276
[TBL] [Abstract][Full Text] [Related]
32. Induction of B cell lymphomas by overexpression of a Myb oncogene truncated at either terminus.
Press RD; Wisner TW; Ewert DL
Oncogene; 1995 Aug; 11(3):525-35. PubMed ID: 7630637
[TBL] [Abstract][Full Text] [Related]
33. Transcriptional and post-transcriptional regulation of c-myc, c-myb, and p53 during proliferation and differentiation of murine erythroleukemia cells treated with DFMO and DMSO.
Klinken SP; Holmes KL; Morse HC; Thorgeirsson SS
Exp Cell Res; 1988 Oct; 178(2):185-98. PubMed ID: 2458948
[TBL] [Abstract][Full Text] [Related]
34. An oligomer complementary to c-myb-encoded mRNA inhibits proliferation of human myeloid leukemia cell lines.
Anfossi G; Gewirtz AM; Calabretta B
Proc Natl Acad Sci U S A; 1989 May; 86(9):3379-83. PubMed ID: 2541445
[TBL] [Abstract][Full Text] [Related]
35. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation.
Liebermann DA; Hoffman B
Stem Cells; 1994 Jul; 12(4):352-69. PubMed ID: 7951003
[TBL] [Abstract][Full Text] [Related]
36. A chronic inflammatory response. Its role in supporting the development of c-myb and c-myc related promonocytic and monocytic tumors in BALB/c mice.
Wolff L; Mushinski JF; Shen-Ong GL; Morse HC
J Immunol; 1988 Jul; 141(2):681-9. PubMed ID: 2838552
[TBL] [Abstract][Full Text] [Related]
37. Constitutive ubiquitination and degradation of c-myb by the 26S proteasome during proliferation and differentiation of myeloid cells.
Feiková S; Wolff L; Bies J
Neoplasma; 2000; 47(4):212-8. PubMed ID: 11043824
[TBL] [Abstract][Full Text] [Related]
38. Susceptibility and resistance to Moloney murine leukemia virus-induced promonocytic leukemia.
Nazarov V; Hilbert D; Wolff L
Virology; 1994 Dec; 205(2):479-85. PubMed ID: 7975249
[TBL] [Abstract][Full Text] [Related]
39. Murine myeloid leukemias with aberrant myb loci show heterogeneous expression of novel myb proteins.
Dudek H; Reddy EP
Oncogene; 1989 Dec; 4(12):1489-95. PubMed ID: 2480562
[TBL] [Abstract][Full Text] [Related]
40. M-CSF and M-CSF-receptor gene expression in acute myelomonocytic leukemias.
Parwaresch MR; Kreipe H; Felgner J; Heidorn K; Jaquet K; Bödewadt-Radzun S; Radzun HJ
Leuk Res; 1990; 14(1):27-37. PubMed ID: 2154646
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
